26792955 27902884 30121880 29632143 27542227 33781946 26357850 27430721 25259411 26272906 27481185 27544210 31512538 30908540 32763309 33771687 32829384 25558972 29938195 26358867 34192992 31877441 27686018 25611933 27815118 25305688 28614794 2513118 - Search Results

Year	Number of Results
2014	14
2015	19
2016	23
2017	15
2018	15
2019	16
2020	11
2021	13
2022	4

1

Targeting Th17 Cells with Small Molecules and Small Interference RNA.

Lin H, Song P, Zhao Y, Xue LJ, Liu Y, Chu CQ. Lin H, et al. Mediators Inflamm. 2015;2015:290657. doi: 10.1155/2015/290657. Epub 2015 Dec 17. Mediators Inflamm. 2015. PMID: 26792955 Free PMC article. Review.

2

Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists.

Hintermann S, Guntermann C, Mattes H, Carcache DA, Wagner J, Vulpetti A, Billich A, Dawson J, Kaupmann K, Kallen J, Stringer R, Orain D. Hintermann S, et al. ChemMedChem. 2016 Dec 16;11(24):2640-2648. doi: 10.1002/cmdc.201600500. Epub 2016 Nov 30. ChemMedChem. 2016. PMID: 27902884

3

Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.

Igaki K, Nakamura Y, Komoike Y, Uga K, Shibata A, Ishimura Y, Yamasaki M, Tsukimi Y, Tsuchimori N. Igaki K, et al. Inflammation. 2019 Feb;42(1):91-102. doi: 10.1007/s10753-018-0875-7. Inflammation. 2019. PMID: 30121880

4

TCF-1 Inhibits IL-17 Gene Expression To Restrain Th17 Immunity in a Stage-Specific Manner.

Zhang J, He Z, Sen S, Wang F, Zhang Q, Sun Z. Zhang J, et al. J Immunol. 2018 May 15;200(10):3397-3406. doi: 10.4049/jimmunol.1800193. Epub 2018 Apr 9. J Immunol. 2018. PMID: 29632143 Free PMC article.

5

RORα and RORγ expression inversely correlates with human melanoma progression.

Brożyna AA, Jóźwicki W, Skobowiat C, Jetten A, Slominski AT. Brożyna AA, et al. Oncotarget. 2016 Sep 27;7(39):63261-63282. doi: 10.18632/oncotarget.11211. Oncotarget. 2016. PMID: 27542227 Free PMC article.

6

Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases.

Ribeiro RFN, Cavadas C, Silva MMC. Ribeiro RFN, et al. Drug Discov Today. 2021 Jul;26(7):1620-1641. doi: 10.1016/j.drudis.2021.03.015. Epub 2021 Mar 27. Drug Discov Today. 2021. PMID: 33781946 Review.

7

Are Th17 cells and their cytokines a therapeutic target in Guillain-Barré syndrome?

Wu X, Wang J, Liu K, Zhu J, Zhang HL. Wu X, et al. Expert Opin Ther Targets. 2016;20(2):209-22. doi: 10.1517/14728222.2016.1086751. Epub 2015 Sep 10. Expert Opin Ther Targets. 2016. PMID: 26357850 Review.

8

Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment.

He Z, Wang F, Ma J, Sen S, Zhang J, Gwack Y, Zhou Y, Sun Z. He Z, et al. J Immunol. 2016 Aug 15;197(4):1148-58. doi: 10.4049/jimmunol.1600548. Epub 2016 Jul 18. J Immunol. 2016. PMID: 27430721 Free PMC article.

9

Tc17 Cells in Immunity and Systemic Autoimmunity.

Liang Y, Pan HF, Ye DQ. Liang Y, et al. Int Rev Immunol. 2015;34(4):318-31. doi: 10.3109/08830185.2014.954698. Epub 2014 Sep 26. Int Rev Immunol. 2015. PMID: 25259411 Review.

10

MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.

Sefik E, Geva-Zatorsky N, Oh S, Konnikova L, Zemmour D, McGuire AM, Burzyn D, Ortiz-Lopez A, Lobera M, Yang J, Ghosh S, Earl A, Snapper SB, Jupp R, Kasper D, Mathis D, Benoist C. Sefik E, et al. Science. 2015 Aug 28;349(6251):993-7. doi: 10.1126/science.aaa9420. Epub 2015 Aug 13. Science. 2015. PMID: 26272906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results